Acute pulmonary oedema is a rare complication of head injury. A case is reported in which the pulmonary oedema was treated initially by tracheal intubation, constant positive airway pressure, ventilation and isoprenaline. Subsequent treatment was by vasodilatation with sodium nitroprusside and phenoxybenzamine and the patient made a good recovery. The findings are discussed in relation to reported experimental work. The aetiology appears to be related to a massive sympathetic discharge leading to systemic vasoconstriction, shift of blood to the pulmonary circulation with left ventricular failure and pulmonary oedema.
INTRODUCTION
Pulmonary oedema may complicate intracranial disease of various aetiologies. I -6 The haemodynamic responses to raised intracranial pressure have been studied in many species other than man. 7 -11 Massive vasoconstriction mediated through the hypothalamus and the sympathetic nervous system appears to play a central role in the pathogenesis of neurogenic pulmonary oedema. 6 Experimental neurogenic pulmonary oedema can be prevented by pretreatment with various drugs, in particular alpha-adrenergic blocking agents. This disease in man is usually fatalY We report a case of gross pulmonary oedema complicating a head injury in which pharmacological peripheral vasodilatation resulted in documented haemodynamic improvement and subsequent recovery.
A twelve-year-old boy weighing 31 kg was admitted to the neurosurgical ward at 6 p.m., one hour after being struck by a car. On admission he was drowsy, irritable and confused. Blood pressure was 130/80, pulse rate 110 per minute. There were no abnormal focal neurological signs. Left-sided fundal hemorrhages were noted. Skull x-rays showed an irregular right-sided occipital skull fracture. Chest x-ray showed normal heart size and clear lung fields shortly after admission. A fractured right clavicle was noted. An intravenous infusion of 5070 dextrose in 0.22% saline at 20 ml/hr was commenced. His state of consciousness remained unaltered for three hours. No vomiting occurred. At this stage, the systemic blood pressure rose abruptly to 1801120 mm Hg and pulse rate slowed to 54 per minute. Shortly afterwards his state of consciousness deteriorated. Wide-spread rales were present on auscultation and he became cyanosed and apnoeic. He was intubated with a 7.0 mm Portex nasotracheal tube. Large quantities of white frothy fluid were seen coming from the trachea during intubation. Frusemide 40 mg was given intravenously and he was transferred to the Intensive Care Unit. He breathed oxygen spontaneously with 12 cms H 20 continuous positive airways pressure' (CPAP). Chest x-ray now showed widespread perihilar opacities consistent with pulmonary oedema. Heart size remained normal. Blood pressure was 90/40 mm Hg, pulse rate lOO per minute and central venous pressure + 1 cm H 20 . An infusion of isoprenaline 2 IJg per minute was commenced and intravenous methicillin, gentamicin and dexamethasone were given. Within one hour there was considerable improvement and minimal secretions were obtained from the endotracheal tube with suction. CPAP was discontinued because of suspected raised intracranial pressure and the isoprenaline infusion ceased. A large diuresis of 450 ml in 90 minutes had occurred and the systemic blood pressure fell to 75/40 mm Hg, so 300 ml of SPPS (Stable Plasma Protein Solution) was administered over the next 30 minutes. The central venous pressure rose from -5 to + 1 cm H 2 0 and blood pressure increased to 105/70 mm Hg. Shortly after the completion of this infusion, pink frothy fluid poured from the endotracheal tube and he again became cyanosed. CPAP of + 12 cm H 2 0 failed to control the pulmonary oedema. Continuous positive pressure respiration (CPPR) was instituted (Bennett PR2 respirator) with peak inspiratory pressure of + 40 cm H 2 0 and positive end expiratory pressure of + 12 cm H 2 0. One hour later PaO, was 110 mm Hg in 100070 O2 • Over the next four hours, central venous pressure was 0 to + 3 cm H 2 0 and arterial blood pressure 80-90 mm Hg systolic. Routine half-hourly endotracheal suction was performed. Within seconds of disconnection from the respirator, large amounts of pink frothy fluid forcibly poured from the endotracheal tube. PaO, fell to 50 mm Hg on 100% oxygen. At 4 a.m. an isoprenaline infusion was recommenced at 2 IJg per minute. No significant change in central venous pressure or systemic blood pressure occurred but within 10 minutes the severity of pulmonary oedema decreased and pulmonary oedema fluid stopped appearing when the patient was disconnected from the respirator. The isoprenaline infusion was continued for 8 hours. At 10 a.m. the next morning PaO, was 75 mm Hg on 80% oxygen. At 3 p.m., 3 hours after cessation of isoprenaline, he became cyanosed while still ventilated as above. Cyanosis persisted despite an increase in peak respiratory pressure to + 45 cm H 2 0 and 100% before and following the intravenous injection of 0.8 mg sodium nitroprusside given over 5 minutes during which 200 ml of Hartmann's solution was infused rapidly to compensate for the increased capacitance of the circulation resulting from vasodilatation. Ten minutes after the pressures had returned to preinjection levels 0.2 mg of isoprenaline was infused over 5 minutes. The pressures are summarised in Figure 1 and Table 1 . The wide pressure variations between inspiration and expiration were probably due to high pressures required to ventilate the patient. The ECG showed evidence of left ventricular strain. The patient was semi-conscious and reacting to painful stimuli during cardiac catheterisation. No alteration in conscious state was observed during the administration of sodium nitroprusside or isoprenaline. Because of the haemodynamic improvement obtained with vasodilatation, phenoxybenzamine 30 mg was administered intravenously at completion of cardiac catheterisation. Intramuscular digoxin 0.5 mg statim and 0.25 mg at 6 hourly intervals for 2 doses and then 0.1 mg bd was These remained normal throughout the period of artificial ventilation. Total serum proteins and serum albumin remained normal during the period of cardiovascular instability. Serum osmolality was also normal on two occasions during the period of acute pulmonary oedema and urinary osmolalities were appropriate. One month after discharge the patient was attending school. There were no abnormal neurological signs and his cerebral state, chest x-ray and electrocardiogram were normal.
DISCUSSION
A sudden shift of blood from the peripheral to the pulmonary circulation may precipitate pulmonary oedema l2 -14 due to the rise in pulmonary artery and venous pressures I5 ,16,11 and pulmonary capillary wedge pressure. 5 In experimental neurogenic pulmonary oedema detailed haemodynamic data in many species other than man show conclusively that peripheral vasoconstriction, both arterial and venous, result in a significant shift of blood volume to the pulmonary circulation. 7 ,8 This is mediated by a central sympathetic discharge, and can be prevented by various drugs including alpha-adrenergic blocking agents. 9 Left ventricular failure may occur as a result of increased afterload and be aggravated by coexisting myocardial insufficiency. Experimentally, excessive circulating catecholamines or intense cardiac sympathetic stimulation may cause impairment of left ventricular function. Histological damage in rat myocardium has been noted after head inj ury17 and evidence suggests that this is mediated by catecholamine. Cardiomyopathy may occur in phaeochromocytoma. 18 In 1966 Pleuckahn l9 reported post mortem histological myocardial changes in 40070 of adolescents who survived more than 6 hours after head injury. In two of these ECG abnormalities were noted prior to death. An abnormal electrocardiogram is found in some cases of subarachnoid haemorrhage, with or without pulmonary oedema. 20 Myocardial insufficiency may thus complicate head injury and this can result in pulmonary oedema when a sudden and severe afterload occurs due to sympathetically mediated peripheral vasoconstriction.
Other factors may also be involved in the pathogenesis of pulmonary disturbances associated with intracranial disease. Decreased lung compliance and surfactant alterations have been demonstrated following both cerebral injury and administration of catecholamines in several species. 21 -23 A direct neural pathway affecting capillary permeability has been postulated,24 but there is no direct evidence for this and the observed phenomena can be adequately explained by the mechanisms above.
The sequence of haemodynamic changes in experimental neurogenic pulmonary oedema is well documented and has important therapeutic implications. Ducker et al. 8 showed a consistent response to raised intracranial pressure produced by an epidural balloon in chimpanzees. Moderate elevation caused increases in central venous pressure, venous return and mild systemic hypertension and bradycardia were noted. Further increases in intracranial pressure resulted in a significant increase in peripheral vascular resistance, a decreased cardiac output and an increase of up to 45% in central blood volume. In some animals, these changes occurred with only mild increases in mean pulmonary artery pressures, and no pulmonary oedema occurred. In others, this same sequence of events was followed by a sudden massive increase in peripheral vascular resistance, leading to abrupt decrease in cardiac output to 50% of normal. Then followed left atrial distension and large increases in pulmonary venous pressure to 40 mm Hg or more. Pulmonary artery pressure also increased and fulminating pulmonary oedema occurred when pulmonary venous pressure transiently exceeded pulmonary arterial pressure. A similar sequence of haemodynamic events has also been demonstrated in dogs,25,11 rats 7 ,9 and monkeys,ll with minor species variation. A central sympathetic discharge is primarily responsible for the sequence of events in susceptible animals, this being confirmed by the protection offered by high cervical cordotomy.7 Decerebration and adrenalectomy had no protective effect suggesting that the discharge originates in the bnrin stem and that adrenal catecholamine secretion is not essential. 7 Adrenergic blockade prevents both neurogenic pulmonary oedema 7 and adrenaline induced pulmonary oedema 25 and also abolishes the compliance changes seen after head injury in animals . 19 In contrast to the extensive data available in animal studies, there is little information relating to man. The onset of pulmonary oedema often follows immediately after the head injury.6 In 1969 Simmons et al. 27 reported pulmonary oedema in 17 out of 20 young men dying within minutes of being shot through the head. Weisman 28 (1939) noted that pulmonary oedema was present in eight patients dying almost instantaneously after head trauma. Pulmonary oedema did not occur if there was massive blood loss at the time of injury, or if high spinal transection had occurred. Ducker l2 (1968) also reviewed the clinical details of eleven patients with neurogenic pulmonary oedema. The only survivor had urgent surgical relief of raised intracranial pressure. In all cases, the pulmonary oedema was severe and fulminating in onset, occurring usually several hours after the cerebral insult. Nine of the eleven patients had normal central venous pressure measurements. All were young and had no evidence of pre-existing cardiopulmonary disease. In our patient the onset of pulmonary oedema occurred four hours after injury.
In a review of non-cardiogenic forms of pulmonary oedema, Karliner 29 in 1972 suggested that the experimental data described above were not relevant to man. He claimed firstly that the occurrence of pulmonary oedema within minutes of head injury mitigated against the mechanism proposed above. However, Chen 7 showed that in rats this is precisely the time sequence of neurogenic pulmonary oedema mediated by sympathetic vasoconstriction after severe head inj ury. Secondly, he claimed that neurogenic pulmonary oedema occurred without significant abnormalities in systemic arterial pressure but in the eleven patients reported by Ducker!2 three had hypertension and bradycardia, two did not, and in the other six patients no recordings were reported prior to the onset of pulmonary oedema. Ciongoli and Posner 30 in 1972 also cast doubt on the occurrence of left ventricular failure in neurogenic pulmonary oedema. They reported three patients with documented subarachnoid haemorrhage who developed pulmonary oedema. An isolated measurement of normal central venous pressure in these three patients is Anaesthesia and Intensive Care, Vol. VIII. No. 1. claimed to support the concept of an extracardiac origin of the pulmonary oedema. This conclusion is unjustified. Detailed haemodynamic observations in chimpanzees 8 and dogs!! with neurogenic pulmonary oedema showed that central venous pressure remained normal despite grossly elevated left ventricular end-diastolic, left atrial and pulmonary artery pressures.
Theodore and Robin 6 suggested from the evidence available the following pathogenesis for neurogenic pulmonary oedema. A centrally mediated, massive sympathetic discharge causes generalized vasoconstriction with shift of systemic blood to the lower pressure pulmonary circulation. This results in a rise in pulmonary vascular pressures and a marked increase in pulmonary blood volume causing an increased hydrostatic pressure and damage to the pulmonary capillary endothelium. Pulmonary capillary damage leading to increased permeability is suggested by the high protein content of the oedema fluid and the presence of red cells in the air spaces. 24 The hypertension may be transient but the patient may be left with abnormal pulmonary capillary permeability so that pulmonary oedema persists in the face of normal haemodynamics.
Our patient became hypertensive four hours after the injury and then pulmonary oedema developed. The arterial pressure fell to 90/40 mm Hg and the CVP was normal. Although CP AP and CPPR were necessary to control the pulmonary oedema it lessened on two occasions with an isoprenaline infusion.
The haemodynamic data from our patient obtained by cardiac catheterisation showed evidence of left ventricular failure and pulmonary arterial hypertension during established severe neurogenic pulmonary oedema. Left ventricular failure was immediately relieved by sodium nitroprusside which produces a rapid onset of peripheral vasodilatation. This lasts only a few minutes unless given as an infusion. 3I • 32 An infusion of isoprenaline improved left ventricular function. This may be related to both the positive inotropic effect and the peripheral vasodilatation achieved. Following alphaadrenergic blockade with phenoxybenzamine 1 mg/kg there was sustained clinical and biochemical improvement. The rapidity of this improvement suggested that digitalization which was commenced simultaneously did not contribute significantly.
Webre, Benbau and Arens 33 in 1972 concluded that continuous positive pressure breathing is the only method by which neurogenic pulmonary oedema can be controlled and suggested that digoxin and diuretics play little part in the management. They questioned the use of alpha-adrenergic blockade in this situation because systemic blood pressure is lowered and cerebral circulation, normally preserved by the Cushing reflex, may be impaired. This is a justifiable concern, particularly when cerebral oedema is present and careful consideration of the possible advantages against the hazards should be made before vasodilating a patient with raised intracranial pressure. However, systemic blood pressure is usually normal or low once neurogenic pulmonary oedema is established both in man and animals. This may be related to left ventricular failure and reduced cardiac output. In our patient, systemic blood pressure increased after alpha-adrenergic blockade and a fluid load, probably as a result of reduced afterload and increased cardiac output. A positive inotropic effect of phenoxybenzamine has also been suggested. 34 The use of IPPR or CP AP in the presence of raised intracranial pressure is also undesirable. Peripheral vasodilatation may make these measures unnecessary especially if initiated promptly as redistribution of central blood volume back to the systemic circulation will occur. In conclusion, the reported data support the hypothesis that the pathogenesis of neurogenic pulmonary oedema in man is similar to that in other species and is due to intense vasoconstriction. The catheter studies in our patient suggest that left ventricular failure contributed to the pulmonary oedema.
Vasodilator treatment with, for example, an alpha-adrenergic blocker such as phenoxybenzamine may be applicable in man as it is in other species but this should be used with caution when intracranial pressure is raised. The high mortality associated with neurogenic pulmonary oedema probably justifies a trial of vasodilatation. The short action of sodium nitroprusside allows a trial of treatment before commencing more prolonged therapy with phenoxybenzamine.
